222 related articles for article (PubMed ID: 24967588)
1. Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.
Ferrari N; Mohammed ZM; Nixon C; Mason SM; Mallon E; McMillan DC; Morris JS; Cameron ER; Edwards J; Blyth K
PLoS One; 2014; 9(6):e100759. PubMed ID: 24967588
[TBL] [Abstract][Full Text] [Related]
2. Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.
Uzelac B; Krivokuca A; Brankovic-Magic M; Magic Z; Susnjar S; Milovanovic Z; Supic G
Pathol Oncol Res; 2020 Oct; 26(4):2723-2731. PubMed ID: 32681437
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.
Gujam FJ; Edwards J; Mohammed ZM; Going JJ; McMillan DC
Br J Cancer; 2014 Jul; 111(1):157-65. PubMed ID: 24874480
[TBL] [Abstract][Full Text] [Related]
4. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
[TBL] [Abstract][Full Text] [Related]
5. ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer.
Beltjens F; Molly D; Bertaut A; Richard C; Desmoulins I; Loustalot C; Charon-Barra C; Courcet E; Bergeron A; Ladoire S; Jankowski C; Boidot R; Arnould L
Int J Cancer; 2021 Jul; 149(1):200-213. PubMed ID: 33634878
[TBL] [Abstract][Full Text] [Related]
6. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience.
Nwafor CC; Keshinro SO
Niger J Clin Pract; 2015; 18(4):553-8. PubMed ID: 25966732
[TBL] [Abstract][Full Text] [Related]
7. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
8. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.
Mohammed ZM; Going JJ; Edwards J; Elsberger B; Doughty JC; McMillan DC
Br J Cancer; 2012 Aug; 107(5):864-73. PubMed ID: 22878371
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
10. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
Choi JS; Kim KH; Oh E; Shin YK; Seo J; Kim SH; Park S; Choi YL
Pathology; 2017 Oct; 49(6):618-626. PubMed ID: 28818465
[TBL] [Abstract][Full Text] [Related]
11. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
12. Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.
Chimge NO; Ahmed-Alnassar S; Frenkel B
Cell Cycle; 2017 Feb; 16(4):312-318. PubMed ID: 28055379
[TBL] [Abstract][Full Text] [Related]
13. Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.
Guo J; Gong G; Zhang B
Tumour Biol; 2017 Jul; 39(7):1010428317713392. PubMed ID: 28671019
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer.
Alexopoulou AN; Ho-Yen CM; Papalazarou V; Elia G; Jones JL; Hodivala-Dilke K
BMC Cancer; 2014 Apr; 14():237. PubMed ID: 24693876
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer.
Li X; Song C; Wang K; Li N; Sun S; Li N; Zhao Z; Li M
Cancer Biomark; 2019; 25(1):19-27. PubMed ID: 31033460
[TBL] [Abstract][Full Text] [Related]
16.
Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
[No Abstract] [Full Text] [Related]
17. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
[TBL] [Abstract][Full Text] [Related]
18. RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.
Chimge NO; Little GH; Baniwal SK; Adisetiyo H; Xie Y; Zhang T; O'Laughlin A; Liu ZY; Ulrich P; Martin A; Mhawech-Fauceglia P; Ellis MJ; Tripathy D; Groshen S; Liang C; Li Z; Schones DE; Frenkel B
Nat Commun; 2016 Feb; 7():10751. PubMed ID: 26916619
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor α associated with triple-negative breast cancer and poor prognosis.
Zhang Z; Wang J; Tacha DE; Li P; Bremer RE; Chen H; Wei B; Xiao X; Da J; Skinner K; Hicks DG; Bu H; Tang P
Arch Pathol Lab Med; 2014 Jul; 138(7):890-5. PubMed ID: 24028341
[TBL] [Abstract][Full Text] [Related]
20. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]